Arlington Partners LLC Cuts Position in RELX PLC $RELX

Key Points

• Arlington Partners LLC has decreased its stake in Relx Plc by 6.6%, owning 83,112 shares after selling 5,887 shares during the second quarter.
• Several analysts have recently updated their ratings on Relx, with Morgan Stanley maintaining an "overweight" rating, while Kepler Capital Markets upgraded it to a "strong-buy" rating.
• Relx announced a semi-annual dividend of $0.2634 per share, with a payout ratio of 27.96% and a yield of 170.0% as of September 16th.

Arlington Partners LLC cut its holdings in shares of RELX PLC (NYSE:RELX - Free Report) by 6.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 83,112 shares of the technology company's stock after selling 5,887 shares during the quarter. RELX makes up 1.7% of Arlington Partners LLC's investment portfolio, making the stock its 23rd largest holding. Arlington Partners LLC's holdings in RELX were worth $4,516,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. ABC Arbitrage SA grew its position in shares of RELX by 40.1% during the 1st quarter. ABC Arbitrage SA now owns 194,197 shares of the technology company's stock valued at $9,789,000 after acquiring an additional 55,579 shares during the period. Charles Schwab Investment Management Inc. increased its position in RELX by 16.5% in the first quarter. Charles Schwab Investment Management Inc. now owns 167,175 shares of the technology company's stock worth $8,427,000 after buying an additional 23,692 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in shares of RELX by 4.5% in the first quarter. Goldman Sachs Group Inc. now owns 4,072,342 shares of the technology company's stock valued at $205,287,000 after buying an additional 173,976 shares during the period. Pandora Wealth Inc. purchased a new position in shares of RELX during the 1st quarter valued at $757,000. Finally, Massachusetts Financial Services Co. MA lifted its position in shares of RELX by 103.7% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 106,220 shares of the technology company's stock valued at $5,355,000 after buying an additional 54,062 shares during the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

RELX Trading Up 0.0%

Shares of NYSE RELX traded up $0.00 during midday trading on Monday, reaching $47.03. The company had a trading volume of 756,498 shares, compared to its average volume of 1,493,622. The stock has a market cap of $86.19 billion, a PE ratio of 25.29, a price-to-earnings-growth ratio of 3.07 and a beta of 0.87. RELX PLC has a one year low of $44.19 and a one year high of $56.33. The firm's fifty day moving average price is $49.00 and its 200-day moving average price is $51.08. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55.

RELX Cuts Dividend

The business also recently declared a semi-annual dividend, which was paid on Tuesday, September 16th. Investors of record on Friday, August 8th were issued a $0.2634 dividend. The ex-dividend date was Friday, August 8th. This represents a yield of 170.0%. RELX's payout ratio is 28.49%.

Wall Street Analyst Weigh In

Several research firms have commented on RELX. Kepler Capital Markets raised shares of RELX from a "hold" rating to a "strong-buy" rating in a report on Thursday. Morgan Stanley restated an "overweight" rating on shares of RELX in a research note on Thursday, September 11th. Finally, Wall Street Zen downgraded shares of RELX from a "buy" rating to a "hold" rating in a report on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the company's stock. According to data from MarketBeat, RELX has an average rating of "Buy".

RELX Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.